The Journal of Urology
Volume 183, Issue 1 , Pages 234-240 , January 2010

Long-Term Durability of Percutaneous Tibial Nerve Stimulation for the Treatment of Overactive Bladder

  • Scott A. MacDiarmid

      Affiliations

    • Alliance Urology Specialists, Greensboro, North Carolina
    • Corresponding Author InformationCorrespondence: Alliance Urology Specialists, Bladder Control and Pelvic Pain Center, 509 N. Elam Ave., Second Floor, Greensboro, North Carolina 27403 (telephone: 336-274-1114; FAX: 336-232-5337)
    • Financial interest and/or other relationship with Uroplasty, Pfizer, Watson, Astellas and Allergan.
    • ,
  • Kenneth M. Peters

      Affiliations

    • William Beaumont Hospital, Royal Oak, Michigan
    • Financial interest and/or other relationship with Medtronic, Advanced Bionics, Boston Scientific, Allergan, Pfizer, Celgene and Trillium Therapeutics.
    • ,
  • S. Abbas Shobeiri

      Affiliations

    • University of Oklahoma, Oklahoma City, Oklahoma
    • ,
  • Leslie S. Wooldridge

      Affiliations

    • Mercy Health Partners, Muskegon, Michigan
    • Financial interest and/or other relationship with Uroplasty, Astellas and Watson.
    • ,
  • Eric S. Rovner

      Affiliations

    • Medical University of South Carolina, Charleston, South Carolina
    • Financial interest and/or other relationship with Uroplasty, Pfizer, Allergan, Tengion, Solace, Contura and Astellas.
    • ,
  • Fah Che Leong

      Affiliations

    • St. Louis University, St. Louis, Missouri
    • Financial interest and/or other relationship with Astellas.
    • ,
  • Steven W. Siegel

      Affiliations

    • Metro Urology, Woodbury, Minnesota
    • Financial interest and/or other relationship with AMS, Medtronic, Uromedica, Uroplasty and QiG.
    • ,
  • Susan B. Tate

      Affiliations

    • University of Louisville, Louisville, Kentucky
    • Financial interest and/or other relationship with C. R. Bard.
    • ,
  • Brian A. Feagins

      Affiliations

    • Dallas Center for Pelvic Medicine, Dallas, Texas
    • Financial interest and/or other relationship with Medtronic, AMS, Novartis, Allergan, Astellas and Boston Scientific.

Received 20 June 2009

 Supported by Uroplasty, Inc.

 Study received institutional review board approval.

 See Editorial on page 17.

PII: S0022-5347(09)02381-7

doi: 10.1016/j.juro.2009.08.160

The Journal of Urology
Volume 183, Issue 1 , Pages 234-240 , January 2010

Article Tools

* Image Usage & Resolution